Literature DB >> 12959026

[Incidence of anaerobic bacteria in respiratory tract infections].

Anna Kedzia1, Ewa Kwapisz, Maria Wierzbowska.   

Abstract

Anaerobic bacteria are predominant components of normal oral cavity, upper respiratory tract, gastrointestinal, genital and skin flora. They are involved in infections such as pneumonia, aspiration pneumonia, lung abscess and empyema. Laboratory diagnosis of anaerobic infections is based on recovering the etiological agents from clinical materials. Appropriatte specimens include: pus, purulent fluid, biopsy specimen of lung, transtracheal aspirates and bronchoalveolar lavage (BAL). Lower respiratory infections are usually either polymicrobial or mixed anaerobic-aerobic infections. Peptostreptococcus, Fusobacterium, Prevotella and Bacteroides are the most common anaerobes. Anaerobic bacteria are susceptible to metronidazole, tinidazole (exception of Gram-positive rods), amoxicillin/clavulanate, ampicillin/sulbactam, piperacillin/tazobactam, imipenem and clindamycin. Treatment includes an antibiotics regimen with an agent active against anaerobic and aerobic bacteria (therapy with 2 or 3 antimicrobial drugs).

Entities:  

Mesh:

Year:  2003        PMID: 12959026

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  3 in total

Review 1.  Rare case of Prevotella pleuritidis lung abscess.

Authors:  Abuzar Ali Asif; Moni Roy; Sharjeel Ahmad
Journal:  BMJ Case Rep       Date:  2020-09-07

2.  Bioaerosols Play a Major Role in the Nasopharyngeal Microbiota Content in Agricultural Environment.

Authors:  Hamza Mbareche; Marc Veillette; Jonathan Pilote; Valérie Létourneau; Caroline Duchaine
Journal:  Int J Environ Res Public Health       Date:  2019-04-16       Impact factor: 3.390

3.  First Korean case of Robinsoniella peoriensis bacteremia in a patient with aspiration pneumonia.

Authors:  Yongbum Jeon; Taek Soo Kim; Hong Bin Kim; Kyoung Un Park; Junghan Song; Eui Chong Kim
Journal:  Ann Lab Med       Date:  2012-08-13       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.